Customize
Quick Links
Past Events

Accreditation/
Credit Designation

Physicians' Education Resource®, LLC is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Physicians' Education Resource®, LLC designates this live activity for a maximum of 7.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Commercial Supporters

This activity is supported by educational grants from Celgene Corporation and Lilly USA, LLC.
About
Accreditation
Privacy Policy
Terms & Conditions
Executive Board
Journal
Faculty Portal
Contact
Facebook
Twitter
LinkedIn
Google +
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 800-210-2873

Copyright © 2017
Physicians’ Education Resource ®, LLC.
All rights reserved.

7th Annual New York Lung Cancer Symposium®

7th Annual New York Lung Cancer Symposium®


Overview

The 7th Annual New York Lung Cancer Symposium® is a one-day meeting which will serve as an update on advances in the field and will focus on the future of lung cancer treatment including: molecular subsets, targeted agents in development, treatment options in early stage, screening, the ongoing guideline debate, and a look forward from the experts.

Participants will learn from engaging presentations delivered by thought leaders and by reviewing and discussing realistic and complex scenarios, sharing clinical experiences, understanding well-established and emerging unmet therapeutic opportunities, solving clinical problems, and clarifying best practices. Participants will actively respond to and interact with the faculty through informal questions and open discussion, and as a result of this approach will leave with a higher level of understanding than they would otherwise achieve.

Target Audience

This educational activity is directed toward medical oncologists, radiation oncologists, thoracic surgeons, pulmonologists involved in the treatment and management of patients with lung cancer.  Fellows, nurse practitioners, nurses, physician assistants, pharmacists, researchers, and other health care professionals interested in the treatment of lung cancer may also participate.

Learning Objectives

  • Evaluate emerging clinical data regarding new agents and evolving strategies for the treatment of lung cancer, and apply clinical trial data appropriately in order to optimize the outcome of individual patients
  • Use histologic and molecular data, tumor and patient characteristics, in order to individualize therapy choices for your patients with NSCLC






Become a Member

Forgot Password?
Filter By